Marshall Wace, LLP Sab Biotherapeutics Inc Wt Exp Transaction History

Marshall Wace, LLP

$74.4 Billion
Q1 2025

A detailed history of Marshall Wace, LLP transactions in Sab Biotherapeutics Inc Wt Exp stock. As of the latest transaction made, Marshall Wace, LLP holds 247,576 shares of SABSW stock, worth $7,427. This represents 0.0% of its overall portfolio holdings.

Number of Shares

247,576

Holding current value

$7,427

% of portfolio

0.0%

0 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form

No transaction found.

Others Institutions Holding SABSW

# of Institutions

Shares Held

862K

Call Options Held

62.5K

Put Options Held

Lmr Partners LLP London, X0

540K
Shares

$16,187
0.0% of portfolio
Morgan Stanley New York, NY

146K
Shares

$4,393
0.0% of portfolio
Yakira Capital Management, Inc. Westport, CT

78.7K
Shares

$2,361
0.0% of portfolio
Hb Wealth Management, LLC

60K
Shares

$1,800
0.0% of portfolio
Walleye Trading LLC Plymouth, MN

31.9K
Shares

$955
0.0% of portfolio

View Full List

About SAB BIOTHERAPEUTICS INC WT EXP

Ticker SABSW
Sector Healthcare
Industry Biotechnology

More about SABSW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Sab Biotherapeutics Inc Wt Exp Transaction History